Table 4.

Baseline Hemostatic Features of Patients With ALI/ALF According to the Occurrence of Bleeding Complications During the First 7 Days of Study Admission

	Number Analyzed	No Bleeding Complications (n = 626)	Number Analyzed	Bleeding Complications (n = 50)
VWF (%) (95% CI)*	622	441.9 (424.5‐459.4)	50	523.2 (467.1‐579.3)
ADAMTS13 (%) (95% CI) †	621	21.6 (19.7‐23.5)	49	15.1 (10.9‐19.2)
ETP (nM IIa*min) (95% CI)	607	543.4 (517.3‐569.6)	49	634.3 (394.3‐874.4)
CLT > 180 minutes (%) (95% CI)	597	64.3 (60.5‐68.2)	44	65.9 (51.3‐80.5)

Data are presented as mean (95% CI) or percentage (95% CI).

^* P < 0.05.

^†P < 0.01.